Skip to content

Adherence to Lung Cancer Screening by Low-dose Thoracic CT in Haut-Rhin Department, France.

Adherence to Lung Cancer Screening by Low-dose Thoracic CT in Haut-Rhin Department, France.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06020443
Acronym
DECANPHAR
Enrollment
126
Registered
2023-08-31
Start date
2023-11-06
Completion date
2026-11-01
Last updated
2026-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-Risk Cancer, Lung Cancer

Keywords

screening, low dose chest computed tomography, lung cancer

Brief summary

The main objective of the study is to measure adherence to a lung cancer screening program using low-dose thoracic CT.

Detailed description

Secondary objectives 1. To evaluate patient compliance over the entire duration of the screening program 2. To assess patient smoking cessation 3. To describe radiation doses received during CT scans 4. To identify organizational constraints for general practitioners 5. To compare stages at diagnosis before and after implementation of screening program Conduct of research Eligible patients will be identified by general practitioners. Patients included will require a low-dose thoracic CT scan to be performed by a radiologist of their choice. Smoking cessation will be systematically proposed, and will be carried out by the general practitioner or a tobaccologist. The radiation dose from thoracic CT scans should not exceed 100 mGy.cm Product Dose Length (i.e. \< 1.5 mSv). Imaging reports will be forwarded to the general practitioner. If the first CT scan is negative (T0): a second scan will be scheduled 1 year later (T1). If this second scan is also negative, in the absence of lung cancer risk factors other than smoking, scans will then be performed every two years. In the presence of a risk factor for lung cancer (other than tobacco), screening will remain annual. In the event of a result classified as uncertain: a follow-up scan is scheduled at 3 months ; if the follow-up scan is negative, the next screening will be scheduled 1 year after this follow-up scan. If the screening performed 1 year later is also negative, subsequent screenings will be performed annually. In the event of a positive result: the general practitioner will refer the patient to a pneumologist of his/her choice for further examinations; data from these additional examinations will be collected. The screening protocol may evolve in line with recommendations issued by the French National Authority for Health (HAS). For participants undergoing CT scan at the imaging department of Emile Muller hospital in Mulhouse (GHRMSA), a blood sample will be collected (optional) for subsequent biomarker assays.

Interventions

PROCEDURELow Dose chest CT Scan for Lung Cancer Screening

Low dose CT scans will be performed for three years

Sponsors

Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Low Dose chest CT Scan for Lung Cancer Screening

Eligibility

Sex/Gender
ALL
Age
50 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 50 to 74 years * Smoking OR having smoked (withdrawal of \<15 years): ≥15 cigarettes/day for ≥25 years OR ≥10 cigarettes/day for ≥30 years * Affiliated or beneficiary of a social security scheme * Written informed consent

Exclusion criteria

* Inability to walk up two flights of stairs without stopping * BMI \> 35 kg/m² * Recent chest CT scan \< 1 year * Personal history of lung cancer \< 5 years or under treatment * Personal history of cancer being monitored by chest CT scan * Contraindication to lung cancer treatment or diagnostic investigations * Current or recent respiratory symptoms immediately suggestive of lung cancer * Pregnant or breast-feeding woman * Person under court protection, guardianship or curatorship * Person deprived of liberty by judicial or administrative decision.

Design outcomes

Primary

MeasureTime frame
Rate of included patients having undergone the first screening scanT0

Secondary

MeasureTime frameDescription
Rate of patients who refused to participate in the screening program1 year
Rate of included patients having completed CT scans at each stage of follow-up3 years
Number of patients newly committed to smoking cessation during the screening period3 years
Tobacco consumption3 years
Radiation doses received at each CT scan3 years
Organizational constraints of the screening programbefore starting the studyOrganizational constraints of the screening program will be assessed on a subgroup of general practitioners by semi-structured interviews
Stage at diagnosis (TNM classification) of patients with lung cancer3 yearsThe stages at diagnosis of patients with lung cancer included in the study will be compared with those of undetected patients (data from the Haut-Rhin Cancer Registry).

Countries

France

Contacts

PRINCIPAL_INVESTIGATORPatrick Strentz, MD

General Practioner, Colmar, France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 9, 2026